Phase II Trial of Target-guided Personalized Chemotherapy in First-line Metastatic Colorectal Cancer.
作者： Antonio Cubillo , Jesús Rodriguez-Pascual , Fernando López-Ríos , Carlos Plaza , Elena García
DOI: 10.1097/COC.0000000000000045
关键词: Internal medicine 、 Response Evaluation Criteria in Solid Tumors 、 Clinical trial 、 Precision medicine 、 Colorectal cancer 、 Performance status 、 Irinotecan 、 Oncology 、 Chemotherapy 、 Medicine 、 Oxaliplatin
摘要: Purpose:The aim of this study was to investigate the feasibility and efficacy personalizing treatment patients with advanced untreated colorectal cancer (CRC).Patients Methods:Patients metastatic CRC, performance status 0-1, candidates for systemic chemotherapy were elig
elsevier.com
sci-hub.se 参考文章(30)
L C Shea, B Gustavsson, T Horikoshi, K D Danenberg, T H Stadlbauer, M Ray, K Aigner, R Frösing, M Volkenandt, L Leichman, Quantitation of Thymidylate Synthase, Dihydrofolate Reductase, and DT-Diaphorase Gene Expression in Human Tumors Using the Polymerase Chain Reaction Cancer Research. ,vol. 52, pp. 108- 116 ,(1992)
Peter V. Danenberg, Jan Brabender, David Sidransky, James Engles, Carmen Jerónimo, Henning Usadel, Stephen Yang, Susan Harden, Kathy D. Danenberg, Quantitative Adenomatous Polyposis Coli Promoter Methylation Analysis in Tumor Tissue, Serum, and Plasma DNA of Patients with Lung Cancer Cancer Research. ,vol. 62, pp. 371- 375 ,(2002)
Bárbara Angulo, Elena García-García, Rebeca Martínez, Ana Suárez-Gauthier, Esther Conde, Manuel Hidalgo, Fernando López-Ríos, A Commercial Real-Time PCR Kit Provides Greater Sensitivity than Direct Sequencing to Detect KRAS Mutations The Journal of Molecular Diagnostics. ,vol. 12, pp. 292- 299 ,(2010) , 10.2353/JMOLDX.2010.090139
H J Lenz, C G Leichman, K D Danenberg, P V Danenberg, S Groshen, H Cohen, L Laine, P Crookes, H Silberman, J Baranda, Y Garcia, J Li, L Leichman, Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. Journal of Clinical Oncology. ,vol. 14, pp. 176- 182 ,(1996) , 10.1200/JCO.1996.14.1.176
C G Leichman, H J Lenz, L Leichman, K Danenberg, J Baranda, S Groshen, W Boswell, R Metzger, M Tan, P V Danenberg, Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. Journal of Clinical Oncology. ,vol. 15, pp. 3223- 3229 ,(1997) , 10.1200/JCO.1997.15.10.3223
Levi A. Garraway, Genomics-Driven Oncology: Framework for an Emerging Paradigm Journal of Clinical Oncology. ,vol. 31, pp. 1806- 1814 ,(2013) , 10.1200/JCO.2012.46.8934
Ken A Olaussen, Ariane Dunant, Pierre Fouret, Elisabeth Brambilla, Fabrice André, Vincent Haddad, Estelle Taranchon, Martin Filipits, Robert Pirker, Helmut H Popper, Rolf Stahel, Laure Sabatier, Jean-Pierre Pignon, Thomas Tursz, Thierry Le Chevalier, Jean-Charles Soria, None, DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. The New England Journal of Medicine. ,vol. 355, pp. 983- 991 ,(2006) , 10.1056/NEJMOA060570
A S Strimpakos, K N Syrigos, M W Saif, Pharmacogenetics and biomarkers in colorectal cancer. Pharmacogenomics Journal. ,vol. 9, pp. 147- 160 ,(2009) , 10.1038/TPJ.2009.8
HL McLeod, WN Keith, Variation in topoisomerase I gene copy number as a mechanism for intrinsic drug sensitivity. British Journal of Cancer. ,vol. 74, pp. 508- 512 ,(1996) , 10.1038/BJC.1996.394
Wasaburo Koizumi, Isao Okayasu, Ichinosuke Hyodo, Junichi Sakamoto, Hiroshi Kojima, Prediction of the effect of capecitabine in gastric cancer by immunohistochemical staining of thymidine phosphorylase and dihydropyrimidine dehydrogenase. Anti-Cancer Drugs. ,vol. 19, pp. 819- 824 ,(2008) , 10.1097/CAD.0B013E3283094B5D